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Abstract:  The cyanobacteria or “blue-green algae”, as they are commonly termed, 
comprise a diverse group of oxygenic photosynthetic bacteria that inhabit a wide range of 
aquatic and terrestrial environments, and display incredible morphological diversity. Many 
aquatic, bloom-forming species of cyanobacteria are capable of producing biologically 
active secondary metabolites, which are highly toxic to humans and other animals. From a 
toxicological viewpoint, the cyanotoxins span four major classes: the neurotoxins, 
hepatotoxins, cytotoxins, and dermatoxins (irritant toxins). However, structurally they are 
quite diverse. Over the past decade, the biosynthesis pathways of the four major 
cyanotoxins: microcystin, nodularin, saxitoxin and cylindrospermopsin, have been 
genetically and biochemically elucidated. This review provides an overview of these 
biosynthesis pathways and additionally summarizes the chemistry and toxicology of these 
remarkable secondary metabolites. 
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1. Microcystin 
1.1. Introduction 
The heptapeptide hepatotoxin, microcystin, has been isolated from multiple genera of 
cyanobacteria, including Microcystis, Anabaena, Oscillatoria, Planktothrix, Chroococcus and Nostoc. 
Microcystin-producing strains such as Microcystis aeruginosa have a cosmopolitan distribution and 
thrive in a range of climates, making these organisms a global threat to human health. Consequently, 
significant research efforts have been directed towards their identification and eradication. 
1.2. Chemistry 
The microcystins comprise the largest and most structurally diverse group of cyanobacterial toxins. 
Around 90 microcystin isoforms varying by degree of methylation, hydroxylation, epimerization, 
peptide sequence and toxicity have been identified [1,2]. Underlying the extraordinary heterogeneity 
present among the microcystins is their common cyclic structure (Figure 1) and possession of several 
rare, highly conserved amino acid moieties. Collectively, the microcystins may be described as 
monocyclic heptapeptides containing both D- and L-amino acids plus N-methyldehydroalanine and a 
unique ß-amino acid side-group, 3-amino-9-methoxy-2-6,8-trymethyl-10-phenyldeca-4,6-dienoic acid 
(Adda) [3]. The microcystin isoforms differ primarily at the two L-amino acids, and secondarily on the 
presence or absence of the methyl groups on D-erythro--methylaspartic acid (D-MeAsp) and/or   
N-methyldehydroalanine (Mdha) [4]. However, substitutions of all moieties within microcystin have 
been reported [5–7]. 
Figure 1. Structure of microcystin. General numbering of residues is indicated. 
Microcystin is a cyclic heptapeptide. The two variable amino acids in microcystin are 
indicated by X and Y. The most common isoform is microcystin-LR (MW 995.17), where 
X is L-Leu and Y is L-Arg. 
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1.3. Toxicology 
Acute cases of microcystin poisoning may cause rapid death in humans and other animals [8]. Upon 
ingestion, microcystin is transported to the liver by organic anion transport proteins where they exert 
their toxicity via inhibition of protein phosphatases 1 and 2A [9–11]. Inhibition of protein 
phosphatases can lead to excessive phosphorylation of structural filaments, subsequent cyto-skeletal 
degradation and breakdown of hepatic ultra structure [12,13]. Retraction of hepatocytes from 
neighboring cells and sinusoidal capillaries causes blood to become pooled in the liver tissues. This 
ultimately results in local tissue damage, organ failure and haemorrhagic shock [13].  
Varying levels of toxicity have been reported for each microcystin isoform. For example, the LD50 
of the most common isoform, microcystin-LR, is 50 µg per kilogram of body weight in mice [14], 
while the rarer microcystin-RR requires a significantly higher dose of 600 µg to produce the same 
lethal effect [15]. 
The revelation that cyanobacterial hepatotoxins cause protein phosphatase inhibition has raised the 
disturbing possibility that human exposure to non-lethal doses of these compounds may contribute to 
the development of cancer [16,17]. Several laboratory studies have indicated that chronic exposure to 
microcystin can indeed promote skin and liver tumors in rats and mice [18,19]. Epidemiological data 
suggest that similar long-term effects such as hepatocellular carcinoma may also be observed in 
humans [20,21]. Such results highlight the need for sensitive and rapid detection methods and stringent 
monitoring of cyanobacterial hepatotoxins in drinking water supplies. 
1.4. Biosynthesis and Genetics 
Microcystin is synthesized non-ribosomally by the thiotemplate function of a large multifunctional 
enzyme complex containing both non-ribosomal peptide synthetase (NRPS) and polyketide synthase 
(PKS) domains. The gene cluster encoding these biosynthetic enzymes, mcyS, has been sequenced and 
partially characterized in several cyanobacterial species including Microcystis,  Anabaena, and 
Planktothrix [22–24] (Figure 2). Such fundamental studies have offered insight into the evolution of 
cyanotoxin biosynthesis, and have additionally provided much of the groundwork for current   
PCR-based cyanobacterial detection methods. 
The microcystin biosynthesis gene cluster, mcyS, was the first complex metabolite gene cluster to 
be fully sequenced from a cyanobacterium. In M. aeruginosa PCC7806, the mcyS gene cluster spans 
55 kb and comprises 10 genes arranged in two divergently transcribed operons, mcyA–C and mcyD–J. 
The larger of the two operons, mcyD–J, encodes a modular PKS (McyD), two hybrid enzymes 
comprising NRPS and PKS modules (McyE and McyG), and enzymes putatively involved in the 
tailoring (McyJ, F, and I) and transport (McyH) of the toxin. The smaller operon, mcyA–C encodes 
three NRPSs (McyA–C) [22]. 
The formation of Adda putatively involves enzymes encoded by mcyD–G  and  J, based on 
bioinformatic analyses and homology to related enzymes (Figure 3a). The hybrid NRPS/PKS enzyme, 
McyG, constitutes the first step in Adda biosynthesis. It was initially hypothesized that the NRPS 
module of McyG activates phenylacetate, however, recent biochemical characterization of the McyG 
A–PCP didomain has revealed that assorted phenylpropanoids are preferentially activated and loaded Mar. Drugs 2010, 8                                 
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onto the PCP [25]. Following activation, the phenylpropanoid starter unit is extended by several 
malonyl-CoA elongation steps and subsequently modified by C-methylation, reduction and 
dehydration, all catalyzed by the PKS modules of McyD, E and G. The aminotransferase domain of 
McyE then converts the polyketide to a -amino acid in the final step of Adda biosynthesis. The NRPS 
module of the second hybrid PKS/NRPS enzyme, McyE, is thought to be involved in the activation 
and condensation of D-Glu with Adda. 
Figure 2. Hepatotoxin gene clusters from various cyanobacteria. Structures of the 
microcystin and nodularin gene clusters of (A) N. spumigena, (B) M. aeruginosa,   
(C) P. agardhii, and (D) Anabaena sp. 90, showing genes encoding polyketide synthases 
(white), non-ribosomal peptide synthetases (red), tailoring enzymes (grey), and   
ABC-transporters (black). Diagram not drawn to scale. 
 
 
The  mcyF ORF was originally predicted to encode a glutamate racemase, responsible for the 
epimerization of the L-Glu residue of microcystin [22,26]. A subsequent study by [27] contended this 
theory and offers evidence that McyF acts exclusively as an Asp racemase. The authors propose that 
the  D-Glu residue is provided by an L-Glu racemase residing outside the mcyS  gene cluster. 
Mutagenesis experiments in P. agardhii showed that the production of Adda also involves an   
O-methylation step catalyzed by the putative monofunctional tailoring enzyme, McyJ [23]. 
The remaining biosynthetic enzymes in the microcystin biosynthesis pathway (NRPSs) are 
putatively involved in the specific activation, modification and condensation of substrate amino acids 
onto the linear peptide chain, which is then cyclized to produce microcystin. Firstly, McyA adds   
L-Ser to the growing chain, followed by the addition of D-Ala. This step is followed by the addition of 
L-Leu and D-MeAsp residues (McyB) followed by the addition of L-Arg (McyC), and subsequent 
cyclization and release of the final peptide product (Figure 3b). 
The remaining stand alone enzyme, the 2-hydroxy-acid dehydrogenase, McyI, is putatively 
involved in the production of D-methylaspartate at position three within the microcystin cyclic 
structure via the conversion of 3-methylmalate to 3-methyloxalacetate. It is hypothesized that a 
promiscuous aspartate aminotransferase then converts 3-methyloxalacetate to methylaspartate [28]. 
An ABC transporter gene, mcyH, is believed to be involved in the transport of microcystin [29]. 
This transporter may be responsible for the thylakoid localization of the toxin [30,31] or for the 
extrusion of the toxin under certain growth conditions, including exposure to high and red light [32]. Mar. Drugs 2010, 8                                 
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Figure 3. (uper) Model for the formation of Adda during microcystin biosynthesis and 
predicted domain structure of McyG, McyD and McyE. (lower) Biosynthetic model for 
microcystin-LR and predicted domain structure of McyE, McyA, McyB, and McyC. Each 
circle and rectangle represents, respectively, a PKS or NRPS enzymatic domain. The 
aminotransferase domain is represented by a diamond. The activity of the tailoring ORFs, 
McyJ, F and I, are shown as inverted triangles. Abbreviations are as follows: A, aminoacyl 
adenylation; ACP, acyl carrier protein; AMT, aminotransferase; AT, acyltransferase;   
C, condensation; CM, C-methyltransferase; DH, dehydratase; Ep, epimerization; KR, 
ketoacyl reductase; KS, β-ketoacyl synthase; NM, N-methyltransferase;  
OM, O-methyltransferase; RC, racemase; TE, thioesterase. The NRPS thiolation motif is 
shown in black (reproduced from [22]). 
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Comparative studies of the mcyS gene clusters from M. aeruginosa, P. agardhii [23], and Anabaena 
sp. [24] have noted variation in the arrangement of mcyS genes between these different species of 
cyanobacteria, although the proposed toxin biosynthetic processes are thought to be similar. The   
M. aeruginosa and Anabaena sp. mcyS clusters are both arranged into two divergently transcribed 
operons, however, the arrangement of genes within these operons differs between the two species 
(Figure 2). In P. agardhii, the mcyS cluster also has a distinctive arrangement and lacks mcyF and 
mcyI. Furthermore, the P. agardhii mcyS cluster contains an additional gene mcyT, upstream of the 
central promoter region. This gene is thought to encode a putative type II thioesterase enzyme, which 
may play an editing role by removing mis-primed amino acids from the NRPS and PKS enzymes. The 
characterization of mcyS in M. aeruginosa, P. agardhii and Anabaena sp. has important implications 
for understanding the origins and evolution of hepatotoxin biosynthesis in cyanobacteria. The 
identification of transposases associated with the mcyS and ndaS  (nodularin)  gene clusters and 
subsequent phylogenetic analysis has led to the theory that horizontal gene transfer and recombination 
events are responsible for the sporadic distribution of the mcyS gene cluster throughout the 
cyanobacteria and the various microcystin isoforms that have been identified to date [22,33,34]. 
Hepatotoxin production in cyanobacteria is thought to be influenced by a number of different 
physical and environmental parameters, including nitrogen, phosphorous, trace metals, growth 
temperature, light, and pH [35–41]. However, due to the fact that most regulatory investigations have 
not been standardized, and the data have not been interpreted against the same specific growth 
controls, the subject of hepatotoxin regulation remains a somewhat contentious issue. While most toxin 
regulation studies have focused on direct measurements of cellular toxin, the description of the mcy 
gene cluster by Tillett and co-workers [22] enabled a closer examination of microcystin regulation at 
the molecular level [32]. Kaebernick et al. used the RNase protection assay to measure the 
transcription of mcyB and mcyD under a variety of different light conditions. High light intensities and 
red light were correlated with increased transcription, while blue light led to reduced transcript levels. 
Interestingly, the authors observed two light thresholds, between dark and low light (0 and 16 µmol 
photons m
-2 s
-1), and medium and high light (31 and 68 µmol photons m
-2 s
-1), at which a significant 
increase in transcription occurred. The same group later found that transcription of mcy genes occurs 
via two polycistronic operons, mcyABC and mcyDEFGHIJ,  from a central bidirectional promoter 
between mcyA and mcyD [42]. Interestingly, alternate transcriptional start sites were identified for both 
operons when cells were cultured under different light intensities. For example, under low light 
conditions, the polyketide and tailoring genes mcyD–J  are transcribed as part of a polycistronic 
message (mcyDEFGHIJ) from a central (mcyD) promoter, while under high light conditions, the genes 
are transcribed from an alternative up-stream promoter. It is thought that initiation from the alternate 
promoters under high light conditions may lead to increased transcription, as previously observed for 
mcyB and mcyD.  Many of the tailoring enzymes (mcyF, G, H, I and  J) also possess their own 
individual promoters [32].  
Interestingly, light intensity also appears to favor the production of certain microcystin variants 
over others. For example, Tonk et al. (2005) found that the cellular content of total
 microcystin 
remained constant, independent of the irradiance.
 However, of the two main microcystin variants 
detected in P.
 agardhii, the microcystin-DeRR content decreased two-fold with
 increased photon 
irradiance, whereas the microcystin-DeLR content
 increased three-fold. Since microcystin-DeLR is Mar. Drugs 2010, 8                                 
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considerably
 more toxic than microcystin-DeRR, this implies that P. agardhii
 becomes more toxic at 
high light intensities [40]. 
Other factors such as nutrient content and temperature have also been demonstrated to affect mcyS 
expression and toxin biosynthesis. For example, Sevilla et al. (2008) investigated the effect of iron on 
mcyS expression and toxin biosynthesis in M. aeruginosa PCC7806 [41]. Real-time PCR analysis and 
HPLC were used to measure transcription of mcyD and the synthesis of microcystin-LR, respectively. 
The results of this study suggested that iron starvation causes an increase in mcyD transcription, 
correlative to the increase of toxin levels [41]. Davis et al. (2009) investigated the effects of 
temperature on Microcystis growth and toxin genes and found that elevated temperatures yield more 
toxic Microcystis cells and/or cells with more mcyD copies per cell, with either scenario potentially 
yielding more toxic blooms [39]. 
2. Nodularin 
2.1. Introduction 
The cyclic pentapeptide nodularin is most commonly isolated from the filamentous, planktonic 
cyanobacterium, Nodularia spumigena. This species generally forms toxic blooms in brackish and 
estuarine environments. Blooms of toxic N. spumigena occur annually during summer months in the 
Baltic Sea [43] resulting in nodularin being one of the most abundant naturally occurring compounds 
in the Baltic Sea. Blooms are also particularly common within the estuaries and coastal lagoons of 
Australia [44,45], and have been reported worldwide, including on the German North Sea coast [46], 
New Zealand [47], and North America [48]. N. spumigena scums have also been reported in the fresh 
to brackish/saline lakes at the mouth of the lower River Murray, South Australia, which is a major 
source of both potable and irrigation water [49]. Nodularin is structurally similar to microcystin and 
can induce similar toxic effects. The toxin has been reported to have detrimental effects on numerous 
organisms within the ecosystem, including invertebrates and fish, but may have no effect on other 
organisms [50]. 
The consumption of water containing toxic N. spumigena blooms has led to the death of domestic 
and native animals by massive liver haemorrhage [46,47,51,52]. In sub-acute doses, nodularin, like 
microcystin, is thought to act as a liver tumor initiator and promoter [53]. N. spumigena blooms are 
also of importance to the seafood industry. Nodularin has been shown to accumulate in shellfish and 
other seafood. Surveys of mussels, prawns, flounder both in Australia and the Baltic Sea report that 
nodularin accumulated to levels of concern with the potential to cause hepatotoxicity [54–56].  
2.2. Chemistry 
Nodularin is a cyclic pentapeptide with a similar structure to microcystin, consisting of Adda,   
D-glutamic acid (D-Glu),  N-methyldehydrobutyrine (MeDhb), D-erythro--methylaspartic acid   
(D-MeAsp), and L-arginine (L-Arg) (Figure 4) [57]. 
Seven naturally-occurring isoforms of nodularin have been reported to date. Two of these isoforms, 
produced by a New Zealand Nodularia sp. bloom, have variations within the Adda residue, which 
reduces or abolishes the toxicity of the compound [5]. The D-Glu residue is essential for toxicity of Mar. Drugs 2010, 8                                 
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nodularin, as esterification of its free carboxyl abolishes toxicity, however, substitution at position 1 
has little effect on toxicity. The other two isoforms, nodularin-Har and motuporin, are variable at 
position 2. Nodularin-Har is produced by the strain N. harveyana PCC7804, with the L-Arg, replaced 
with  L-Homoarginine (L-Har) [58,59]. Motuporin has been isolated from the Papua New Guinea 
sponge Theonella swinhoei, and may be synthesized by an associated cyanobacterium. The L-Arg 
residue of nodularin is replaced by L-Val in motuporin [60]. The L-Val residue is responsible for 
additional cytotoxicity of motuporin against cancer cell lines. 
Figure 4. Structure of nodularin. General numbering of residues is indicated. Nodularin is 
a cyclic pentapeptide (MW 619). The L-Arg residue of nodularin may be replaced with a 
homoarginine (nodularin-Har) or valine residue (motuporin). 
 
2.3. Toxicology 
Nodularin is a potent hepatotoxin in humans and other animals. Nodularin induces liver hemorrhage 
in mice and has a lethal dose 50 (LD50) of 50 g.kg
-1 (intra-peritoneal route of injection) in mice [61]. 
At doses below this concentration, nodularin may act as a carcinogen via the initiation and promotion 
of liver cell division [53]. 
The hepatotoxicity and carcinogenicity of nodularin is associated with the inhibition of eukaryotic 
protein phosphatase (PP) catalytic subunit types 1 and 2A [62]. The toxin inhibits the activity of PP2A 
to a greater extent than PP1. Inhibition of PP2A by nodularin occurs at relatively the same 
concentration (IC50) as that of microcystin (~0.1 nM) [62]. The hydrophobic C20 - amino acids Adda, 
present in both toxins, blocks PP enzyme activity by interacting with the hydrophobic groove and 
obstructing substrate access to the active site cleft [63–65]. MeDhb binds to Cys273 of PP2A in a 
similar fashion to the MeDha residue in microcystin which binds to Cys273 of PP1 and Cys266 of 
PP2A [64,66], however, binding of the toxin does not occur covalently and may be the reason for its 
additional carcinogenic properties [67]. 
The toxic effects of nodularin are primarily associated with the hepatocytes due to active transport 
of the toxin to the liver via the bile acid multi-specific organic anion transporters [10]. To date, studies 
have been unable to identify the specific mechanism of transport. 
Nodularin has been observed to accumulate on different trophic levels, in numerous organisms 
including waterfowl, fish, mysid shrimp, zooplankton and benthic organisms [68]. Mesozooplankton 
in particular seem to play a major role in nodularin transfer to planktivorous fish [68]. The toxin Mar. Drugs 2010, 8                                 
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appears to cause oxidative stress in the tissues in which it accumulates. In the case of the flounder 
(platichthys flesus L.), this oxidative stress occurs in the liver by way of reduced GST and CAT 
activities [69]. However, recent studies suggest that the toxin is rapidly detoxified and broken down or 
excreted [70]. 
2.4. Biosynthesis and Genetics 
The nodularin biosynthesis gene cluster ndaS, from Nodularia spumigena NSOR10, was sequenced 
and characterized in 2004 by Moffitt and Neilan [71]. The 48 kb region of the genome consists of nine 
ORFs (ndaA-I) transcribed from a bidirectional regulatory promoter region (Figure 2). While most of 
the ndaS encoded genes have homologs in the mcyS cluster, their arrangement adheres more closely to 
the ‘co-linearity’ rule of NRPS pathways that predicts the order of catalytic processes involved in the 
biosynthesis of a non-ribosomal metabolite is generally the same as the order of the genes which 
encode their catalytic enzymes [72]. 
The proposed pathway for nodularin biosynthesis is similar to that for microcystin. Functional 
assignment of the enzymes was based on bioinformatic analysis and homology to the microcystin 
synthetase enzymes. The Adda side-chain is produced via a mixed NRPS/PKS pathway from a 
phenylacetate starter unit and several malonyl-CoA extensions (NdaC, D and F) (Figure 5). The NRPS 
module of the hybrid NRPS/PKS, NdaF, subsequently adds D-Glu to the growing chain. Two NRPS 
enzymes, NdaA and B, complete the cyclic pentapeptide by adding the final amino acid residues,  
L-Thr, D-MeAsp and L-Arg. The NRPS modules responsible for the activation of D-Ala and D-Leu in 
mcyS (McyA and B) are absent from ndaS as nodularin lacks these moieties. The NRPS and PKS 
proteins require posttranslational modification by a phosphopantetheinyl transferase (PPT) protein. 
The PPT required for activation of the Nda proteins is not clustered with the other nda genes. Recently, 
degenerate PCR and subsequent functional enzymatic characterization, identified the PPT required for 
nodularin biosynthesis in N. spumigena NSOR10 [73]. 
The ndaS cluster also encodes several putative monofunctional tailoring enzymes that may play a 
role in the modification and transport of nodularin. ndaE encodes an O-methyltransferrase,  ndaG 
encodes a putative L-Asp/L-Glu racemase, and ndaI encodes an ABC transporter. Also encoded within 
the ndaS cluster is a D-3-PGDH homolog, NdaH, which shares 71% identity with McyI. It is likely 
therefore, that NdaH may be involved in the production of D-MeAsp [28]. 
Like mcyS, the ndaS gene cluster is transcriptionally regulated by a bi-directional promoter region. 
Analysis of transcription of the ndaS cluster found that it is transcribed as two polycistronic mRNA, 
ndaAB, ORF1, and ORF2, and ndaC [71]. The two genes downstream of ndaAB, ORF1 and ORF2, 
encode a putative transposase and a putative high light-inducible chlorophyll-binding protein, 
respectively. It is not clear why the putative transposase and the putative high light-inducible 
chlorophyll-binding protein are also co-transcribed with the ndaS gene cluster. ORF2 has been 
identified in all strains of toxic Nodularia and the association between ORF2 and nodularin 
biosynthesis may suggest a physiological function associated with high-light stress in the cells 
producing it. A putative heat shock repressor protein, encoded by the gene ORF3, was also identified 
downstream of ORF2, which may be involved in the transcriptional regulation of the ndaS genes in 
response to heat stress. Mar. Drugs 2010, 8                                 
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Figure 5. (uper). Model of the formation of Adda during nodularin biosynthesis and 
predicted domain structure of NdaC, D and F. (lower). Biosynthetic model for nodularin 
and predicted domain structure of NdaF, H, A and B. Each grey and green circle 
represents, respectively, a PKS or NRPS enzymatic domain. The activities of the tailoring 
ORFs, NdaE, G and H, are shown as inverted triangles. Abbreviations are as follows:  
A, aminoacyl adenylation; ACP, acyl carrier protein; AMT, aminotransferase;   
AT, acyltransferase; C, condensation; CM, C-methyltransferase; DH, dehydratase;   
Ep, epimerization; KR, ketoacyl reductase; KS, β-ketoacyl synthase; NM,   
N-methyltransferase; OM, O-methyltransferase; RC, racemase; TE, thioesterase. 
(reproduced from [71]).  
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More recently, elucidation of the nda cluster has provided an opportunity to monitor transcriptional 
regulation of the biosynthetic pathway [74]. The effects of ammonia and phosphate starvation were 
analyzed. While expression of the nda cluster appears to be constitutive, phosphate starvation resulted 
in an approximately two-fold increase in expression, while ammonia supplementation decreased 
expression two-fold. Despite the changes to expression, intracellular and extracellular nodularin 
concentration remained stable [74]. 
3. Saxitoxin 
3.1. Introduction 
Saxitoxin and its analogs, collectively termed paralytic shellfish poisons (PSPs), are highly potent 
neurotoxins. Several freshwater species of cyanobacteria and marine dinoflagellates are known to 
produce saxitoxins. Blooms of these toxic species have led to mass kills of fish, native animals and 
livestock, as well as the contamination of freshwater resources [75–77]. Saxitoxins typically 
accumulate through the food chain, in organisms consumed as seafood [78]. Marine shellfish are 
particularly resistant to the toxins, and can therefore accumulate dangerously high levels of PSPs by 
ingesting toxic plankton [79]. Saxitoxin and its analogs cause an annual estimated 2000 cases of PSP 
globally, with a mortality rate of 15% [80]. 
The capacity to synthesize saxitoxins and other PSPs has an unusually wide phylogenetic 
distribution, including both marine and freshwater organisms from two kingdoms of life (Eubacteria 
and Protista). Typically, there is little convergence between the structures of secondary metabolites 
from marine and freshwater organisms [81], or from organisms belonging to different phylogenetic 
groups. Although several studies suggest that other bacteria are capable of synthesizing PSPs [82,83], 
the findings are controversial, as the analytical methods used were not definitive and could not be 
readily repeated by other researchers [84]. On the other hand, PSP biosynthesis in cyanobacteria and 
dinoflagellates has been extensively verified and shown to be a consistent and heritable genetic   
trait [85–90]. 
In the marine environment, dinoflagellate species capable of producing saxitoxins belong to the 
genera Alexandrium, Pyrodinium and Gymnodinium [91–93]. While in freshwater systems, several 
filamentous species of cyanobacteria, such as Anabaena circinalis,  Aphanizomenon sp., 
Aphanizomenon gracile, Cylindrospermopsis raciborskii and  Lyngbya wollei are also known to 
produce saxitoxins [94–97]. Saxitoxin production is varied among dinoflagellate and cyanobacterial 
producer genera, with not all species in a toxigenic genera being toxic, and different isolates of the 
same species having differential toxicity. Furthermore, cyanobacterial isolates of the same species 
from geographically distant locations provided different toxin profiles [89]. 
3.2. Chemistry 
Saxitoxin is a trialkyl tetrahydropurine and the parent compound of more than 30 naturally 
occurring derivatives that differ structurally at four positions [98] (Figure 6.). The variable positions 
may be hydroxylated, sulfated or carbamoylated. Most of these analogs have been detected in both 
cyanobacteria and dinoflagellates [95,96,98–101]. In addition to the usual carbamate and decarbamoyl Mar. Drugs 2010, 8                                 
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toxins, six new saxitoxin derivatives have been isolated from the cyanobacteria Lyngbya wollei, 
including derivatives which provided an acetyl side-chain instead of the typical carbamate, or lacked 
one of the C-12 hydroxyl moieties [102]. Further unusual modifications, such as a C-11 ethanoic acid 
side-chain [103], or the N-hydroxylation of the carbamoyl side-chain [104], have also been described 
in xanthid crabs. In addition, the freshwater puffer fish was shown to produce a unique saxitoxin 
analog where the carbamoyl side-chain is N-methylated [105]. Furthermore, the Panamanian golden 
frog Atelopus zeteki produces zetekitoxin AB, which was recently confirmed to be a novel analog of 
saxitoxin, with sodium channel blocking activity 580-fold higher than that of saxitoxin [106]. Whether 
or not these complex eukaryotic organisms actually produce PSPs or simply accumulate the toxins in 
their tissues and organs is an issue of contention. 
Figure 6. The core chemical structure of the paralytic shellfish poison (PSP), saxitoxin.  
‘R’ represents variable positions. For a detailed list of isoforms see [98]. 
 
3.3. Toxicology 
Saxitoxin and its derivatives are the causative agents of the common seafood poisoning, paralytic 
shellfish poisoning (PSP). PSP symptoms generally onset within 30 minutes of ingestion, and 
invariably begin with a tingling or burning of the lips, tongue and throat, increasing to total numbness 
of the face [98]. Further symptoms may include perspiration, vomiting and diarrhea. In cases of acute 
poisoning, numbness may spread to the neck and extremities and progress to muscular weakness, loss 
of motor coordination, and finally paralysis. A lethal dose of saxitoxin usually results in cardiovascular 
failure due to respiratory muscle paralysis [98]. There is no clinically approved antidote to saxitoxin 
poisoning, and treatments during early stages of PSP include removal of unabsorbed toxin with 
activated charcoal, and artificial respiration. The half-life of saxitoxin in the body is approximately  
90 minutes, and survival chances increase significantly after 12 hours from initial exposure [107]. It is 
a highly potent blocker of voltage gated sodium channels present in neuronal cell membranes [108]. In 
addition, saxitoxin has also been shown to block calcium channels [109], and to prolong the gating of 
potassium channels in heart muscle cells [110]. Saxitoxin is a highly potent phycotoxin with an 
intraperitoneal LD50 of 10 μg/kg body weight in mice [111], while human death has occurred following 
the ingestion of as little as 1 mg of the toxin [112]. 
Mammals usually contain multiple isoforms of sodium channels, with different sensitivity to 
saxitoxin. This difference in sensitivity is due to variation in the amino acid sequence of the channel 
alpha subunit, whereby a single mutation may confer insensitivity to saxitoxin, though usually Mar. Drugs 2010, 8                                 
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sacrificing speed of gating in the process [113]. The guanidinium groups and the carbon 12 hydroxyls 
in STX have been shown to be critical for the binding of the sodium channel, while the carbamoyl side 
chain also appears to be involved in the binding process, whereby one saxitoxin molecule binds one 
channel by lodging itself in the ion-conducting pore [113–116].  
The toxicity of saxitoxin derivatives varies greatly, with the carbamate toxins being 10–100-times 
more potent than the N-sulfo-carbamoyl derivatives [98,117]. N-sulfo-carbamoyl analogs are, 
however, labile and may easily be converted to the more toxic carbamate derivatives [118,119]. 
3.4. Biosynthesis and Genetics 
Using a reverse genetic approach, Kellmann and co-workers [120] identified the gene cluster 
putatively responsible for the biosynthesis of saxitoxin in Cylindrospermopsis raciborskii T3 (sxt) 
(Figure7c). The sxt gene cluster is encoded by more than 35 kb and comparative sequence analysis 
assigns 30 catalytic functions to 26 proteins. Bioinformatic analysis of this cyanobacterial saxitoxin 
gene cluster, coupled with identification of novel biosynthetic intermediates enabled a revision of the 
previously proposed saxitoxin biosynthesis pathway (Figure 8). 
The first step in the revised saxitoxin biosynthesis pathway involves a Claisen condensation 
reaction catalyzed by SxtA.
 This unique enzyme possesses a polyketide
 synthase (PKS)-like structure 
composed of four
  catalytic domains, SxtA1-4: SxtA1 is homologous to SAM-dependant 
methyltransferases; SxtA2 is related to GCN5-related N-acetyl transferases (GNAT) that transfer 
acetate from acetyl-CoA to various
 heteroatoms [121]; SxtA3 is related
 to ACPs and also provides a 
phosphopantetheinyl-attachment site;
 SxtA4 is homologous to class II aminotransferases and
 is most 
similar to AONS (8-amino-7-oxononanoate synthase).
 The predicted
 reaction sequence of SxtA, based 
on its primary structure, is
 the loading of the ACP (SxtA3) with acetate from acetyl-CoA,
 followed by 
the SxtA1-catalyzed methylation of acetyl-ACP, converting
 it to propionyl-ACP. SxtA4, the class II 
aminotransferase domain,
 then performs a Claisen condensation reaction between propionyl-ACP
 and 
arginine. The putative product of SxtA is thus
 4-amino-3-oxo-guanidinoheptane, which Kellmann et al. 
designated compound
 A. 
The sxtG gene encodes a putative amidinotransferase, with highest
 amino acid sequence similarity 
to L-arginine/L-lysine amidinotransferases. SxtA is the putative substrate for SxtG, which transfers an 
amidino group from
 arginine to the α-amino A' group, thus producing 4,7-diguanidino-3-oxoheptane
 
(designated compound B'). SxtB, an enzyme similar to the
 cytidine deaminase-like enzymes from 
gammaproteobacteria, then catalyzes a retroaldol-like
 condensation in the conversion from B' to C'. 
The putative sterol desaturase, SxtD
 is predicted to introduce a double bond between
 C-1 and C-5 of 
C', resulting in the 1,2-H shift between C-5
 and C-6 (compound D'). The gene product of sxtS, which 
has
  sequence homology to nonheme iron 2-oxoglutarate-dependent dioxygenases, is predicted to
 
perform the consecutive epoxidation of the new double bond and
  opening of the epoxide to an 
aldehyde with concomitant bicyclization.
  SxtU has sequence similarity
  to short-chain alcohol 
dehydrogenases and is therefore predicted to reduce the
 terminal aldehyde group of the saxitoxin 
precursor forming compound E'.
 The concerted action of SxtD, SxtS, and SxtU is therefore responsible
 
for the hydroxylation and bicyclization of compound C' to E'.
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The gene product of sxtI is most similar to a predicted
 O-carbamoyltransferase from Trichodesmium 
erythraeum and other
 cyanobacteria. Kellmann et al.’s data [120] indicate that SxtI may catalyze the 
transfer of a carbamoyl
 group from carbamoylphosphate to the free hydroxy group of E'. Adjacent to 
sxtI are two short ORFs of unknown function, sxtJ and sxtK. While sxtJ and sxtK homologs are 
available in the databases, none of these genes have been functionally characterized. 
sxtH and sxtT, each
  encode a terminal oxygenase subunit similar to those found in bacterial 
phenylpropionate
 and related ring-hydroxylating dioxygenases. SxtH and
 SxtT may therefore perform 
the consecutive hydroxylation of C-12, converting F'
 into saxitoxin.
 Members belonging to bacterial 
phenylpropionate and related
 ring-hydroxylating dioxygenases are multicomponent enzymes,
 as they 
require an oxygenase reductase for their regeneration
 after each catalytic cycle. The sxt gene cluster 
provides a
 putative electron transport system, which would fulfill this
 function in the form of SxtV and 
SxtW. SxtV, a 4Fe-4S ferredoxin, could putatively
 extract an electron pair from succinate, converting 
it to fumarate
 [122]. SxtW a fumarate/reductase/succinate dehydrogenase homolog could then transfer 
the electrons via ferredoxin to SxtH and SxtT. 
Following synthesis of the parent molecule saxitoxin, modifying enzymes
  introduce various 
functional groups. In addition to saxitoxin, C.
 raciborskii T3 produces N-1-hydroxylated (neoSTX), 
decarbamoylated
  (dcSTX), and N-sulfurylated (GTX-5) toxins, whereas Anabaena
  circinalis 
AWQC131C produces decarbamoylated (dcSTX) toxins
 and O-sulfurylated (GTX-3/GTX-2, dcGTX-
3/dcGTX-2) toxins, as
 well as both O- and N-sulfurylated toxins (C-1/C-2), but no N-1-hydroxylated 
toxins [99]. 
sxtX encodes an enzyme with homology to cephalosporin hydroxylase.
 sxtX was detected only in C. 
raciborskii T3, Aphanizomenon flos-aquae
  NH-5, and Lyngbya wollei, which produce   
N-1-hydroxylated analogs
 of saxitoxin [94,108,123], such as neoSTX. This component of the gene
 
cluster was not present in any strain of A. circinalis, and
 therefore probably represents the reason why 
this species does
 not produce N-1-hydroxylated PSP toxins [89,99]. The predicted
 function of SxtX is 
therefore the N-1 hydroxylation of saxitoxin. 
A. circinalis AWQC131C and C. raciborskii T3 also produce N- and O-sulfated analogs of 
saxitoxin [GTX-5, C-2/C-3, (dc)GTX-3/GTX-4].
 The activity of two 3'-phosphate 5'-phosphosulfate 
(PAPS)-dependent
 sulfotransferases, which were specific for the N-21 of saxitoxin and
 GTX-3/GTX-2 
and the O-22 of 11-hydroxy saxitoxin, respectively, has
 been described previously in studies of the 
PSP toxin-producing
 dinoflagellate Gymnodinium catenatum [124,125]. A putative sulfotransferase 
encoded by sxtN is predicted to transfer a sulfate group to either N-21 or O-22. Interestingly,
 the sxt 
gene cluster also encodes an adenylylsulfate kinase (APSK),
  SxtO, putatively involved in the 
formation of PAPS. Other biosynthetic
 gene clusters that result in sulfated secondary metabolites
 also 
contain genes required for the production of PAPS [126]. 
Decarbamoylated analogs of STX could be produced via either
 of two hypothetical scenarios. 
Enzymes that act downstream of
 SxtI, the carbamoyltransferase, in the biosynthesis of PSP toxins
 are 
proposed to exhibit broad substrate specificity, processing
 both carbamoylated and decarbamoylated 
precursors of STX. Alternatively,
 hydrolytic cleavage of the carbamoyl moiety from STX or its
 
precursors may occur. SxtL is related to GDSL lipases, which
 are multifunctional enzymes with 
thioesterase, arylesterase,
 protease, and lysophospholipase activities [127]. The function
 of SxtL could 
therefore include the hydrolytic cleavage of the
 carbamoyl group from STX analogs. Mar. Drugs 2010, 8                                 
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Kinetic studies of PSP toxin accumulation in producing cells
 and the media of cyanobacterial 
cultures suggest that there
 is an active transport mechanism for these toxins [85]. In addition,
 variations 
in the concentration of sodium in culture media are
 known to affect the accumulation of PSP toxins in 
producer cells [128]. sxtF and sxtM encoded two proteins with high sequence
 similarity to sodium-
driven multidrug and toxic compound extrusion
 (MATE) proteins of the NorM family. Members of the 
NorM family
 of MATE proteins are bacterial sodium-driven antiporters that
 export cationic substances 
[129]. All of the PSP toxins are cationic
 substances, except for the C toxins, which are zwitterionic.
 It 
is therefore probable that SxtF and SxtM are also involved
 in the export of PSP toxins. 
Environmental factors such as nutrient (e.g., nitrogen and phosphate) content, salinity and 
temperature
  have been reported to regulate the production of PSP toxins
  in dinoflagellates and 
cyanobacteria [130–132]. Two transcriptional
 factors,  sxtY and sxtZ, related to PhoU and OmpR, 
respectively,
 as well as a two-component regulator histidine kinase proximal
 to the 3' end of the sxt 
gene cluster in C. raciborskii T3 have
 been identified. PhoU-related proteins are negative regulators
 of 
phosphate uptake [133], whereas OmpR-like proteins are involved
 in the regulation of a variety of 
metabolisms, including nitrogen
 [134] and osmotic balance [135]. It is therefore likely that PSP
 toxin 
production in C. raciborskii T3 may be regulated at the
  transcriptional level in response to the 
availability of phosphate
 as well as other environmental factors.  
Figure 7. Structure of the paralytic shellfish toxin biosynthesis cluster (sxt) from;   
(a)  Aphanizomenon  sp. NH-5, (b) Anabaena circinalis AWQC131C,  
(c) Cylindrospermopsis raciborskii T3. Scale indicates gene length in kilobase pairs. Full 
bars and the letters A-E indicate common features between the various sxt gene clusters. 
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Following the identification and characterisation of the sxt cluster from C. raciborskii, Mihali et al. 
[136] have described similar gene clusters from an Australian isolate of Anabaena circinalis and an 
American isolate of Aphanizomenon sp. (Figure 7b and a, respectively). These saxitoxin gene clusters 
are slightly smaller than the C. raciborskii, spanning approximately 28 kb. The topology of all three sxt 
clusters is also varied which suggests the occurrence of multiple transposition events throughout the 
evolution of saxitoxin biosynthesis in the cyanobacteria. Phylogenetic analysis of the sxt  
O-carbamoyltransferase gene across several saxitoxin producing species indicated that the most likely 
origin of the gene was an ancestral a-proteobacterium and that the entire set of genes required for 
saxitoxin biosynthesis probably spread by horizontal gene transfer [137]. 
Figure 8. Proposed saxitoxin biosynthetic pathway in cyanobacteria based on intermediate 
characterization and bioinformatic analysis. Dashed lines indicate possible alternative 
reactions [see text for detailed steps]. 
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4. Cylindrospermopsin 
4.1. Introduction 
The cyanobacterial alkaloid toxin, cylindrospermopsin, was first identified in 1979 when 148 
people were hospitalized with symptoms of hepatoenteritis on Palm Island (Queensland, Australia). 
This outbreak was later linked to a bloom of Cylindrospermopsis raciborskii in a drinking water 
reservoir [138,139]. In addition to its impact on human health, cylindrospermopsin poisonings have 
been linked to the death of domestic animals [140]. 
Eight cyanobacterial species have thus far been identified as cylindrospermopsin producers; 
Cylindrospermopsis raciborskii, Aphanizomenon ovalisporum, Aphanizomenon flos-aquae, Umezakia 
natans,  Rhaphdiopsis curvata and  Anabaena  bergii, Anabaena lapponica, and  Lygnbya wollei   
[141–148]. The wide distribution of cylindrospermopsin producing species, coupled with the 
invasiveness of the chief toxin producer, C. raciborskii, presents a major problem for water 
management, on a global scale [149]. 
4.2. Chemistry 
Cylindrospermopsin is a polyketide-derived alkaloid with a central functional guanidino moiety and 
a hydroxymethyluracil attached to the tricyclic carbon skeleton [150] (Figure 9). The natural 
occurrence of an epimer at the hydroxyl bridge, 7-epicylindrospermopsin [151], and a 
cylindrospermopsin variant lacking the hydroxyl group at C7, 7-deoxycylindrospermopsin, have also 
been reported [143]. 
Figure 9. The chemical structure of the NRPS and PKS derived alkaloid 
cylindrospermopsin. Natural variants containing an epimer at the hydroxyl bridge (C7) or 
lacking the hydroxyl altogether have also been reported [151]. 
 
4.3. Toxicology 
Cylindrospermopsin is a highly biologically active alkaloid, interfering with several metabolic 
pathways. It has hepatotoxic, general cytotoxic [152–154] and neurotoxic [155] effects and is 
considered a potential carcinogen [156]. The toxicity of cylindrospermopsin is mediated through the 
inhibition of glutathione, protein synthesis and cytochrome P450 [152–154,157], with the uracil 
moiety as well as the hydroxyl at C7 being crucial for toxicity [158,151]. In mammals, 
cylindrospermopsin poisoning can cause liver, kidney, thymus and heart damage [159,160]. Mar. Drugs 2010, 8                                 
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4.4. Biosynthesis and Genetics 
The cylindrospermopsin biosynthesis (cyr) gene cluster from C. raciborskii AWT205 was recently 
sequenced [161] The cluster spans 43 kb and contains 15 ORFs, which encode all the functions 
required for the biosynthesis, regulation and export of the toxin (Figure 10). Biosynthesis is initiated 
via an amidinotransfer onto glycine followed by five polyketide extensions and subsequent reductions, 
rings are formed via Michael additions in a step-wise manner. The uracil ring is formed by a novel 
pyrimidine biosynthesis mechanism and tailoring reactions, including sulfation and hydroxylation that 
complete biosynthesis (Figure 11). 
Figure 10. Structural organization of the cylindrospermopsin gene cluster from   
C. raciborskii AWT205. Scale indicates gene cluster in base pairs. 
 
Figure 11. Proposed biosynthetic pathway for cylindrospermopsin (see text for detail). 
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The first step in formation of the carbon skeleton of cylindrospermopsin involves the synthesis of 
guanidinoacetate via the transamidination of glycine [162–164]. An amidinotransferase encoded by 
cyrA, putatively transfers a guanidino group from arginine [163], to glycine thus forming 
guanidinoacetate. A mixed NRPS-PKS encoded by cyrB is thought to activate guanidinoacetate, which 
is then transferred via the swinging arm of the peptidyl carrier protein (PCP) to the KS domain. The 
AT domain of CyrB activates malonyl-CoA and attaches it to the ACP. This is followed by a 
condensation reaction between the activated guanidinoacetate and malonyl-CoA in the KS domain. 
The methyl transferase (MT) domain identified in CyrB is predicted to methylate C13. CyrB contains 
two reducing modules, KR and DH. Their concerted reaction reduces the keto group to a hydroxyl 
followed by elimination of H2O, resulting in a double bond between C13 and C14. A nucleophilic 
attack of the amidino group at N19 onto the newly formed double bond between C13 and C14 then 
putatively occurs via a ‘Michael addition’. The cyclization follows Baldwin’s rules for ring closure 
[165], resulting in the formation of the first ring in cylindrospermopsin. This reaction could be 
spontaneous and may not require enzymatic catalysis, as it is energetically favorable [165]. This is the 
first of three ring formations and is one of the principal differences between Mihali et al.’s [161] 
biosynthetic pathway and that previously proposed [163]. 
The third step in the biosynthesis of cylindrospermopsin involves cyrC, which encodes a PKS with 
KS, AT, KR, and ACP domains. The action of these domains results in the elongation of the growing 
chain by an acetate via activation of malonyl-CoA by the AT domain, its transfer to ACP and 
condensation at the KS domain with the product of CyrB. The elongated chain is bound to the ACP of 
CyrC and the KR domain reduces the keto group to a hydroxyl group on C12. Following the catalysis 
of enzyme CyrC is CyrD, a PKS. The action of this PKS module on the product of CyrC results in the 
addition of one acetate and the reduction of the keto group on C10 to a hydroxyl and dehydration to a 
double bond between C9 and C10. This double bond is the site of a nucleophilic attack by the amidino 
group N19 via another Michael addition that again follows Baldwin’s rules of ring closure [165], 
resulting in the formation of the second ring, the first six-membered ring made in cylindrospermopsin. 
The intermediate produced by CyrD is the substrate for CyrE (step 5 in Figure 1). A PKS, CyrE, 
catalyzes the addition of one acetate and the formation of a double bond between C7 and C8. This 
double bond is attacked by N18 via a Michael addition and the third cyclisation occurs, resulting in the 
second 6-member ring. The cyrF gene encodes the final PKS module - a minimal PKS containing only 
a KS, AT, and ACP. CyrF acts on the product of CyrE and elongates the chain by an acetate, leaving 
C4 and C6 unreduced. Step 7 in the pathway involves the formation of the uracil ring, a reaction that 
has been elusive so far and is required for the toxicity of the final cylindrospermopsin   
compound [151]. 
The cylindrospermopsin gene cluster encodes two enzymes CyrG and CyrH that are most similar to 
the enzyme family of amidohydrolases/ureases/dihydrotases, whose members catalyze the formation 
and cleavage of N-C bonds. Mihali and co-workers [161] propose that these enzymes transfer a second 
guanidino group from a donor molecule, such as arginine or urea, onto C6 and C4 of 
cylindrospermopsin resulting in the formation of the uracil ring. The first reaction consists of the 
formation of a covalent bond between the N of the guanidino donor and C6 of cylindrospermopsin 
followed by an elimination of H2O forming a double bond between C5 and C6. The second reaction 
catalyses the formation of a bond between the second N on the guanidino donor and C4 of Mar. Drugs 2010, 8                                 
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cylindrospermopsin, co-committently with the breaking of the thioester bond between the acyl carrier 
protein of CyrF and cylindrospermopsin, causing the release of the molecule from the enzyme 
complex. The third reaction - if required - would catalyze the cleavage of the guanidino group from a 
donor molecule other than urea. The action of CyrG and CyrH in the formation of the uracil ring in 
cylindrospermopsin describes a novel biosynthesis pathway of a pyrimidine. Mihali and   
co-workers’ [161] genetic analysis shows that cyclization may happen stepwise, with successive ring 
formation of the appropriate intermediate as it is synthesized. This mechanism also explains the lack of 
a thioesterase or cyclization domain, which are usually associated with NRPS/PKS modules and 
catalyze the release and cyclization of the final product from the enzyme complex. 
The sulfation of cylindrospermopsin at C12 is likely to be carried out by the action of a 
sulfotransferase. The cyrJ gene encodes a protein that is most similar to human 3'-phosphoadenylyl 
sulfate (PAPS) dependent sulfotransferases. Similar enzymes have recently been implicated in the 
sulfation of other cyanotoxins [120]. The cylindrospermopsin gene cluster also encodes an 
adenylsulfate kinase (ASK), namely CyrN. ASKs are enzymes that catalyse the formation of PAPS, 
which is the sulfate donor for sulfotransferases. Mihali and co-workers [161] propose that CyrJ sulfates 
cylindrospermopsin at C12 while CyrN creates the pool of PAPS required for this reaction. Screening 
of cylindrospermopsin producing and non-producing strains revealed that the sulfotransferase genes 
were only present in cylindrospermopsin producing strains, further affirming the involvement of this 
entire cluster in the biosynthesis of cylindrospermopsin. The cyrJ gene might therefore be a good 
candidate for a toxin probe, as it is more unique than NRPS and PKS genes and would presumably 
have less cross-reactivity with other gene clusters containing these genes, which are common in 
cyanobacteria. The final tailoring reaction is carried out by CyrI. CyrI putatively catalyzes the 
hydroxylation of C7, a residue that, along with the uracil ring, seems to confer much of the toxicity of 
cylindrospermopsin [158,166]. 
The cylindrospermopsin gene cluster contains an ORF denoted cyrK, the product of which is most 
similar to sodium ion driven multi-drug and toxic compound extrusion proteins (MATE) of the NorM 
family. CyrK is hypothesized to function as a transporter for cylindrospermopsin, based on this 
homology and its central location in the cluster. 
Cylindrospermopsin production has been shown to be highest when fixed nitrogen is eliminated 
from the growth media [167]. Flanking the cylindrospermopsin gene cluster are “hyp” gene homologs 
involved in the maturation of hydrogenases. In the cyanobacterium Nostoc PCC73102 they are under 
the regulation of the global nitrogen regulator NtcA, that activates transcription of nitrogen 
assimilation genes [168,169]. It is plausible that the cylindrospermopsin gene cluster is under the same 
regulation, as it is located wholly within the “hyp” gene cluster in C. raciborskii AWT205, and no 
obvious promoter region in the cylindrospermopsin gene cluster could be identified. Finally, the 
cylindrospermopsin cluster also includes an ORF at its 3’-end designated CyrO. By homology, it 
encodes a hypothetical protein that appears to possess an ATP binding cassette, and is similar to WD 
repeat proteins, which have diverse regulatory and signal transduction roles. CyrO may also have a 
role in transcriptional regulation and DNA binding. It also shows homology to AAA family proteins 
that often perform chaperone-like functions and assist in the assembly, operation, or disassembly of 
protein complexes. Further insights into the role of CyrO are hindered due to low sequence homology 
with other proteins in databases. Mar. Drugs 2010, 8                                 
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